17 March 2025
Vivici secures 'No Questions' FDA letter for precision-fermented whey protein
Dutch start-up Vivici secures a ‘No Questions’ letter from the FDA for its precision-fermented whey protein, Vivitein BLG, a key milestone.
4 March 2025
Vivici brings animal-free protein ingredient to US market
Vivici has launched Vivitein BLG in the US, offering a new protein ingredient for food and beverage companies.
25 February 2025
Vivici secures €32.5m in Series A funding for precision fermentation expansion
Vivici has raised €32.5 million in Series A funding to expand its precision fermentation dairy protein business.
19 February 2024
Vivici achieves GRAS status for its nature-equivalent whey protein
Vivici has announced it has achieved self-affirmed Generally Recognized as Safe status for its beta-lactoglobulin protein in the US.
29 November 2023
Vivici partners with Ginkgo Bioworks to advance alt-dairy protein production
Vivici has entered into a partnership with Ginkgo to advance the production of its sustainable dairy proteins with precision fermentation.
16 August 2023
Vivici enters precision fermentation industry
Vivici has announced that it has successfully closed its seed funding round, with support from founding investors DSM-Firmenich and Fonterra
LATEST NEWS